Abstract:The amicoumacins belong to a class of dihydroisocoumarin natural products and display antibacterial, antifungal, anticancer, and anti-inflammatory activities. Amicoumacins are the pro-drug activation products of a bacterial nonribosomal peptide-polyketide hybrid biosynthetic pathway and have been isolated from Gram-positive Bacillus and Nocardia species. Here, we report the stimulation of a "cryptic" amicoumacin pathway in the entomopathogenic Gram-negative bacterium Xenorhabdus bovienii, a strain not previously known to produce amicoumacins. X. bovienii participates in a multi-lateral symbiosis where it is pathogenic to insects and mutualistic to its Steinernema nematode host. Waxmoth larvae are common prey of the X. bovienii-Steinernema pair. Employing a medium designed to mimic the amino acid content of the waxmoth circulatory fluid led to the detection and characterization of amicoumacins in X. bovienii. The chemical structures of the amicoumacins were supported by 2D-NMR, HR-ESI-QTOF-MS, tandem MS, and polarimeter spectral data. A comparative gene cluster analysis of the identified X. bovienii amicoumacin pathway to that of the Bacillus subtilis amicoumacin pathway and the structurally-related Xenorhabdus nematophila xenocoumacin pathway is presented. The X. bovienii pathway encodes an acetyltransferase not found in the other reported pathways, which leads to a series of N-acetyl-amicoumacins that lack antibacterial activity. N-acetylation of amicoumacin was validated through in vitro protein biochemical studies, and the impact of N-acylation on amicoumacin's mode of action was examined through ribosomal structural analyses.

Five New Amicoumacins Isolated From A Marine-Derived Bacterium Bacillus Subtilis

Amicoumacins from the marine-derived bacterium Bacillus sp. with the inhibition of NO production

Derivatives of Holomycin and Cyclopropaneacetic Acid from Streptomyces Sp Dt-A37

Bisamides and Rhamnosides from Mangrove Actinomycete Streptomyces Sp SZ-A15

New 24-Membered Macrolactines from an Arctic Bacterium Bacillus amyloliquefaciens SCSIO 41392 and Their Anti-Pathogenicity Evaluation

A New Compound from the Marine-Derived Streptomyces Sp. SS13M

Diverse ansamycin derivatives from the marine-derived Streptomyces sp. ZYX-F-97 and their antibacterial activities

Five Polyketides Isolated from the Marine-Derived Fungus Arthrinium Sp.

Hetiamacin E and F, New Amicoumacin Antibiotics from Bacillus subtilis PJS Using MS/MS-Based Molecular Networking

A New Medermycin Analog from the Marine-Derived Actinomycetes Streptomyces Sp. ZS-A45.

Three New Isoflavonoid Glycosides From The Mangrove-Derived Actinomycete Micromonospora Aurantiaca 110b

Two new antifungal cyclic lipopeptides from Bacillus marinus B-9987

Activating and Attenuating the Amicoumacin Antibiotics

Discovery of Three 22-Membered Macrolides by Deciphering the Streamlined Genome of Mangrove-Derived Streptomyces Sp. HM190

Nitricquinomycins A-C, Uncommon Naphthopyrrolediones from the Streptomyces Sp. ZS-A45

Genome Mining, Heterologous Expression, Antibacterial and Antioxidant Activities of Lipoamides and Amicoumacins from Compost-Associated Bacillus subtilis fmb60

Medermycin-Type Naphthoquinones from the Marine-Derived Streptomyces Sp XMA39

Angucycline antibiotics and its derivatives from marine-derived actinomycete Streptomyces sp. A6H

Macrolactin XY, a Macrolactin Antibiotic from Marine-Derived Bacillus subtilis sp. 18

Three New Antibacterial Mycophenolic Acid Derivatives from the Marine‐Derived Fungus Penicillium sp. HN‐66

Bacillibactin and Bacillomycin Analogues with Cytotoxicities against Human Cancer Cell Lines from Marine Bacillus sp. PKU-MA00093 and PKU-MA00092.